140 related articles for article (PubMed ID: 16712676)
21. Sex, age, pubertal development and use of oral contraceptives in relation to serum concentrations of DHEA, DHEAS, 17α-hydroxyprogesterone, Δ4-androstenedione, testosterone and their ratios in children, adolescents and young adults.
Søeborg T; Frederiksen H; Mouritsen A; Johannsen TH; Main KM; Jørgensen N; Petersen JH; Andersson AM; Juul A
Clin Chim Acta; 2014 Nov; 437():6-13. PubMed ID: 24976611
[TBL] [Abstract][Full Text] [Related]
22. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
Meczekalski B; Slopien R; Warenik-Szymankiewicz A
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
[TBL] [Abstract][Full Text] [Related]
23. Sex steroids and bone turnover markers in men with symptomatic vertebral fractures.
Tuck SP; Scane AC; Fraser WD; Diver MJ; Eastell R; Francis RM
Bone; 2008 Dec; 43(6):999-1005. PubMed ID: 18817902
[TBL] [Abstract][Full Text] [Related]
24. Is it necessary to measure free testosterone to assess hyperandrogenemia in women? The role of calculated free and bioavailable testosterone.
Mueller A; Dittrich R; Cupisti S; Beckmann MW; Binder H
Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):182-7. PubMed ID: 16705550
[TBL] [Abstract][Full Text] [Related]
25. Serum levels of androstenedione, testosterone and dehydroepiandrosterone sulfate in patients with premature ovarian failure to age-matched menstruating controls.
Elias AN; Pandian MR; Rojas FJ
Gynecol Obstet Invest; 1997; 43(1):47-8. PubMed ID: 9015699
[TBL] [Abstract][Full Text] [Related]
26. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival.
Jankowska EA; Biel B; Majda J; Szklarska A; Lopuszanska M; Medras M; Anker SD; Banasiak W; Poole-Wilson PA; Ponikowski P
Circulation; 2006 Oct; 114(17):1829-37. PubMed ID: 17030678
[TBL] [Abstract][Full Text] [Related]
27. Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.
Lello S; Primavera G; Colonna L; Vittori G; Guardianelli F; Sorge R; Raskovic D
Gynecol Endocrinol; 2008 Dec; 24(12):718-23. PubMed ID: 19172543
[TBL] [Abstract][Full Text] [Related]
28. Sex hormone-binding globulin and androgen levels in immigrant and British-born premenopausal British Pakistani women: evidence of early life influences?
Pollard TM; Unwin NC; Fischbacher CM; Chamley JK
Am J Hum Biol; 2006; 18(6):741-7. PubMed ID: 17039471
[TBL] [Abstract][Full Text] [Related]
29. Serum total L-carnitine levels in non-obese women with polycystic ovary syndrome.
Fenkci SM; Fenkci V; Oztekin O; Rota S; Karagenc N
Hum Reprod; 2008 Jul; 23(7):1602-6. PubMed ID: 18378560
[TBL] [Abstract][Full Text] [Related]
30. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
31. Breast density in women with premature ovarian failure using hormone therapy.
Benetti-Pinto CL; Soares PM; Magna LA; Petta CA; Dos Santos CC
Gynecol Endocrinol; 2008 Jan; 24(1):40-3. PubMed ID: 18224543
[TBL] [Abstract][Full Text] [Related]
32. [Serum and salivary testosterone levels in erectile dysfunction].
Corradi G; Szathmári M
Orv Hetil; 1998 Aug; 139(34):2021-4. PubMed ID: 9745307
[TBL] [Abstract][Full Text] [Related]
33. Obesity and menstrual irregularity: associations with SHBG, testosterone, and insulin.
Wei S; Schmidt MD; Dwyer T; Norman RJ; Venn AJ
Obesity (Silver Spring); 2009 May; 17(5):1070-6. PubMed ID: 19180069
[TBL] [Abstract][Full Text] [Related]
34. Age and hormone replacement therapy as factors influencing androgen levels in the postmenopausal female.
Ali I; James T; Meston N; Wojnarowska F; Shine B
Clin Chem Lab Med; 2009; 47(2):202-7. PubMed ID: 19191727
[TBL] [Abstract][Full Text] [Related]
35. Associations of adiponectin with sex hormone-binding globulin levels in aging male and female populations.
Yasui T; Tomita J; Miyatani Y; Yamada M; Uemura H; Irahara M; Arai M; Kojimahara N; Okabe R; Ishii Y; Tashiro S; Sato H
Clin Chim Acta; 2007; 386(1-2):69-75. PubMed ID: 17825805
[TBL] [Abstract][Full Text] [Related]
36. Androgens in relationship to cardiovascular risk factors in the menopausal transition.
Mesch VR; Siseles NO; Maidana PN; Boero LE; Sayegh F; Prada M; Royer M; Schreier L; Benencia HJ; Berg GA
Climacteric; 2008; 11(6):509-17. PubMed ID: 18991078
[TBL] [Abstract][Full Text] [Related]
37. High serum sex hormone-binding globulin (SHBG) in premature thelarche.
Belgorosky A; Chaler E; Rivarola MA
Clin Endocrinol (Oxf); 1992 Sep; 37(3):203-6. PubMed ID: 1424201
[TBL] [Abstract][Full Text] [Related]
38. Testosterone/androstenedione ratio in the evaluation of women with ovarian androgen excess.
Wiebe RH; Morris CV
Obstet Gynecol; 1983 Mar; 61(3):279-84. PubMed ID: 6296743
[TBL] [Abstract][Full Text] [Related]
39. Factors associated with bone density in young women with karyotypically normal spontaneous premature ovarian failure.
Leite-Silva P; Bedone A; Pinto-Neto AM; Costa JV; Costa-Paiva L
Arch Gynecol Obstet; 2009 Aug; 280(2):177-81. PubMed ID: 19104824
[TBL] [Abstract][Full Text] [Related]
40. Comparison of salivary versus serum testosterone levels in postmenopausal women receiving transdermal testosterone supplementation versus placebo.
Flyckt RL; Liu J; Frasure H; Wekselman K; Buch A; Kingsberg SA
Menopause; 2009; 16(4):680-8. PubMed ID: 19325500
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
